CARAMBA was presented by the project coordinator Michael Hudecek at The 23rd European Hematology Association in Stockholm (14-17 June 2018). In the course of an educational and scientific programme highlighting state-of-the-art clinical practice and the latest findings in hematology research, Michael Hudecek gave exiting insights into “Non-CD19 future avenues: Myeloma and Myeloid Disorders”, “New targets for CAR-T therapy” and “CAR-T cells: game changer in the treatment of hematologic malignancies”. See webcast sessions at EHA Learning Center

Share This